Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to the integrated physiological system responsible for the transport, storage, and recycling of iron within the human body. It primarily involves iron-binding proteins such as transferrin, which facilitates systemic transport, and ferritin, which serves as the primary intracellular storage vessel (Ganz, T., 2012, Journal of Innate Immunity). The reticuloendothelial system (RES), or mononuclear phagocyte system, consists of specialized macrophages in the spleen, liver, and bone marrow that recycle iron from senescent red blood cells (Abbaspour, N., et al., 2014, Journal of Research in Medical Sciences). In clinical pharmacology, this system is the primary site of action for intravenous iron supplements, such as iron sucrose, which are designed to be captured and processed by RES macrophages (FDA Label: Venofer). Once internalized, these drugs release iron into the intracellular pool to be either stored or exported to transferrin for delivery to the bone marrow for erythropoiesis (StatPearls: Physiology, Iron). Proper functioning of this system is essential for maintaining iron homeostasis and preventing oxidative stress. Pathological states involving this system include iron deficiency anemia, where stores are depleted, and hemochromatosis, where iron accumulates to toxic levels.
Intravenous iron complexes are phagocytosed by macrophages of the reticuloendothelial system, where the iron is released from the carbohydrate shell into the intracellular iron pool to be stored as ferritin or exported via ferroportin to transferrin for systemic transport to the bone marrow.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological iron-binding proteins and reticuloendothelial system cells.